11 reports of this reaction
4.4% of all DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE reports
#1 most reported adverse reaction
PRURITUS is the #1 most commonly reported adverse reaction for DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE, manufactured by Kenvue Brands LLC. There are 11 FDA adverse event reports linking DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE to PRURITUS. This represents approximately 4.4% of all 251 adverse event reports for this drug.
Patients taking DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE who experience pruritus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRURITUS is moderately reported among DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE users, representing a notable but not dominant share of adverse events.
In addition to pruritus, the following adverse reactions have been reported for DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE:
The following drugs have also been linked to pruritus in FDA adverse event reports:
PRURITUS has been reported as an adverse event in 11 FDA reports for DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRURITUS accounts for approximately 4.4% of all adverse event reports for DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE, making it one of the most commonly reported side effect.
If you experience pruritus while taking DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.